SEC Form 4 · accession 0001246360-16-007244
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph E Turk Jr.
Officer — President
Period of report
Nov 25, 2016
Accepted (ET)
Nov 29, 2016 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 25, 2016 | M | 7,000 | $11.03 | A | 86,780 | D | |
| Common Stock | Nov 25, 2016 | M | 2,500 | $18.59 | A | 89,280 | D | |
| Common Stock | Nov 25, 2016 | S | 2,500 | $25.44 | D | 86,780 | D | |
| Common Stock | Nov 25, 2016 | S | 7,000 | $26.03 | D | 79,780 | D | |
| Common Stock | Nov 28, 2016 | M | 2,669 | $18.48 | A | 82,449 | D | |
| Common Stock | Nov 28, 2016 | S | 2,669 | $26.48 | D | 79,780 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $11.03 | Nov 25, 2016 | M | 7,000 | D | Apr 4, 2013 | Mar 3, 2023 | Common Stock | 7,000 | 46,897 | D |
| Stock Option (Right to Buy) | $18.59 | Nov 25, 2016 | M | 2,500 | D | Jun 27, 2011 | May 26, 2018 | Common Stock | 2,500 | 12,723 | D |
| Stock Option (Right to Buy) | $18.48 | Nov 28, 2016 | M | 2,669 | D | Apr 9, 2012 | Mar 8, 2019 | Common Stock | 2,669 | 12,880 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016.